Stem Cell Therapies: Hype, Hope and Evidence-based Decisions

Stem cell therapies are widely marketed to the public for their regenerative properties and their promise to revolutionize medicine. However, despite being widely marketed to the public for their regenerative properties and their promise to revolutionize medicine, stem cell therapies often carry claims that far exceed the known benefits. At best, the procedures are largely ineffective, and at worst, patients are exposed to severe health complications.
At this event, expert panelists Heather Lombardi (Director of the FDA Office of Cellular Therapy and Human Tissues) and Dr. Adrian F. Hernandez (Executive Director of Duke Clinical Research Institute) will discuss proven and unproven stem cell interventions with a focus on the current evidence for clinical use, including what evidence is related to clinical research, how it is obtained and why it is essential.